4-CHLORO-5-METHOXY-2-PHENYLPYRIDAZIN-3(2H)-ONE, 95.0%, 250mg

2-Fluoro-3-methylbenzylamine, 98.0%, 25g

(4R,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one, 98%, 1g

2-chloro-8-methyl-1,4-dihydroquinazolin-4-one, 98+%, 5g

5-FLUORO-7-AZAINDOLE-3-CARBOXYLIC ACID METHYL ESTER, 95.0%, 5g

2,4-Dibromothiazole-5-carboxylic acid, 95.0%, 5g

(2R)-2-AMINO-3,3,3-TRIFLUOROPROPAN-1-OL HCL, 95.0%, 1g

4-Oxocyclohexanecarboxamide, 95.0%, 1g

Acetic acid n-butyl ester, min. 99%, for synthesis, 2.5 l, glass packaging

4-(aminomethyl)-2,3,5,6,7,8-hexahydrocinnolin-3-one hydrochloride, 95.0%, 250mg

Ethyl 6-(trifluoromethyl)nicotinate, 95.0%, 10g

2-Fluoro-6-(trifluoromethyl)benzoic Acid>98.0%(GC)(T)1g

6X Sample Buffer (2-Mercaptoethanol free) [for Electrophoresis]10mL